Calamos Advisors LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2014$334,000
+31.0%
9,4560.0%0.00%0.0%
Q2 2014$255,000
+22.0%
9,456
+17.4%
0.00%
+100.0%
Q1 2014$209,0008,0520.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders